Clinical Trial Update: Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067) [Phase 2]

View source ↗

Summary

A Phase 2 pilot feasibility trial of MK-0991 in patients at high risk for invasive candidiasis in a critical care setting; the study was terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Candidiasis

Drugs mentioned

• MK-0991

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Invasive Candidiasis | Phase 2 | Status: TERMINATED | Results posted: 2013-05-10